Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control (OPTIM@TE)
Primary Purpose
Diabetes Mellitus, Type I
Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Online education programme
Standard education programme
Sponsored by
About this trial
This is an interventional supportive care trial for Diabetes Mellitus, Type I focused on measuring Diabetes Mellitus, Type I, education programme, online
Eligibility Criteria
Inclusion Criteria: HbA1c ≥7,5% More than 3 years of diagnosis Ability to follow online sessions Having a device to follow up the education programme Exclusion Criteria: Pregnants People on corticosteroid treatment People with severe disease People with continuous subcutaneous insulin infusion (CSII)
Sites / Locations
- Hospital Mutua de TerrassaRecruiting
- Hospital Universitari Mútua de TerrassaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Standard care
Online education programme
Arm Description
Group in face-to-face session
Group in online sessions
Outcomes
Primary Outcome Measures
HbA1c
glycosylated hemoglobin
Secondary Outcome Measures
Time in Range (TIR)
Time spent between 70-180 mg/dl measured by glucose sensor
Knowledge related to diabetes management
Diabetes Knowledge Questionnaire (DKQ2)- 15 questions with 4 options, high score indicates maximum level of knowledge
Awareness of hypoglycemia
Clarke Test- 8 questions, ≥ 4 answers with R= reduced awareness
Full Information
NCT ID
NCT05708820
First Posted
March 29, 2022
Last Updated
January 24, 2023
Sponsor
Hospital Mutua de Terrassa
1. Study Identification
Unique Protocol Identification Number
NCT05708820
Brief Title
Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control
Acronym
OPTIM@TE
Official Title
Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 14, 2022 (Actual)
Primary Completion Date
July 31, 2023 (Anticipated)
Study Completion Date
July 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Mutua de Terrassa
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to evaluate the effectiveness of an online intervention for people with type 1 diabetes who present not optimal control of the disease.
Detailed Description
Study area: adults with type 1 diabetes, HbA1c >7.5%, >3 years diagnosed. Methods: randomized clinical trial. It will include 60 participants . The improvement of Glycated Haemoglobin in both groups before and after intervention will be compared; adherence to the treatment, quality of life, time in the glycaemic range, perception of hypoglycaemia and knowledge about diabetes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type I
Keywords
Diabetes Mellitus, Type I, education programme, online
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Standard care
Arm Type
Active Comparator
Arm Description
Group in face-to-face session
Arm Title
Online education programme
Arm Type
Experimental
Arm Description
Group in online sessions
Intervention Type
Behavioral
Intervention Name(s)
Online education programme
Intervention Description
Online group will follow the education programme through videos that they can view at any time and a live session to answer questions.
Intervention Type
Behavioral
Intervention Name(s)
Standard education programme
Intervention Description
Face-to-face educacion programme in a group session
Primary Outcome Measure Information:
Title
HbA1c
Description
glycosylated hemoglobin
Time Frame
Change from Baseline at 12 months
Secondary Outcome Measure Information:
Title
Time in Range (TIR)
Description
Time spent between 70-180 mg/dl measured by glucose sensor
Time Frame
Change from Baseline at 12 months
Title
Knowledge related to diabetes management
Description
Diabetes Knowledge Questionnaire (DKQ2)- 15 questions with 4 options, high score indicates maximum level of knowledge
Time Frame
Change from Baseline at 12 months
Title
Awareness of hypoglycemia
Description
Clarke Test- 8 questions, ≥ 4 answers with R= reduced awareness
Time Frame
Change from Baseline at 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
HbA1c ≥7,5%
More than 3 years of diagnosis
Ability to follow online sessions
Having a device to follow up the education programme
Exclusion Criteria:
Pregnants
People on corticosteroid treatment
People with severe disease
People with continuous subcutaneous insulin infusion (CSII)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Núria Alonso-Carril, RN
Phone
+34 937365050
Ext
11330
Email
nuriaalonso@mutuaterrassa.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Núria Alonso, RN
Organizational Affiliation
Hospital Universitari Mútua Terrassa
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Mutua de Terrassa
City
Terrassa
State/Province
Barcelona
ZIP/Postal Code
08221
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Endocrinology Unit
First Name & Middle Initial & Last Name & Degree
Núria Alonso, RN
Facility Name
Hospital Universitari Mútua de Terrassa
City
Terrassa
State/Province
Barcelona
ZIP/Postal Code
08221
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Núria Alonso-Carril, RN
First Name & Middle Initial & Last Name & Degree
Núria Alonso
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control
We'll reach out to this number within 24 hrs